Freeman, MD, J. (2021) “FDA approves Alzheimer’s drug against the recommendation of its scientific panel. Be very concerned”., RRNMF Neuromuscular Journal, 2(5), pp. 5–6. doi:10.17161/rrnmf.v2i5.15979.